ReviewBreast cancer research : BCR2022

Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancer.

April C Watt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.